文献速递多重用药

减缓处方研究进展的叙述性综述

A narrative review of updates in deprescribing research.
PubMed 文献 · J Am Geriatr Soc · 2021-05-15

该叙述性综述检索了2019年1月1日至2020年8月31日四个数据库的英文文献,初检获199条引用,经全文审阅18篇后选取10篇进行报告。综述总结了减缓处方研究的关键进展,包括错失减缓处方机会、药物与患者层面因素影响不一、不同专科医生观点行为差异,以及临床、财务和经济驱动因素,并指出研究招募困难等优先研究方向。

要点

  • 减缓处方研究关注减少潜在不适当用药相关危害,近年文献增多。
  • 综述发现存在对潜在符合条件患者错失减缓处方机会的情况。
  • 老年科、内科和心内科医生在减缓处方上观点和行为存在差异。

核心结论

  • 该叙述性综述总结了减缓处方领域的关键进展,并确定了需进一步研究的优先领域。

研究设计与样本

  • 叙述性综述,检索四个数据库2019年1月1日至2020年8月31日发表的英文文章。
  • 初检返回199条引用,审阅18篇全文后选取10篇文章进行报告。

主要发现

  • 重要主题包括对潜在符合条件患者错失减缓处方机会,药物和患者层面因素的影响不一。
  • 老年科医生、内科医生和心内科医生在减缓处方上的观点和行为存在差异。
  • 评估了临床、财务和经济驱动因素。
  • 涉及减缓处方研究的问题包括招募试验参与者困难、研究者的观点以及将研究结果整合到临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVES: Deprescribing is a strategy intended to reduce harms associated with potentially inappropriate medications. Reflective of the growing interest in deprescribing, there has been an increase in related research to better understand the landscape, opportunities for improvement, how best to develop and implement interventions, and remaining knowledge gaps that can be addressed with additional study. DESIGN: We conducted a narrative review of recent deprescribing literature. SETTING: As part of the US Deprescribing Network's inaugural conference in October 2020, we presented a narrative review of recent deprescribing literature to an audience with a range of clinical and research expertise. PARTICIPANTS: We searched four databases for English-language articles published between January 1, 2019 and August 31, 2020. MEASUREMENTS: We evaluated titles, abstracts, and full-length manuscripts for relevance, novelty, rigor and variety of methods; we also aimed for broad representation of authors, institutions, and nations. RESULTS: The initial search returned 199 citations, from which we reviewed 18 full-length manuscripts, selecting 10 articles to present. Salient themes included missed opportunities to deprescribe in potentially eligible patients, with variable impact of medication- and patient-level factors, along with differing perspectives and behaviors between geriatricians, internists, and cardiologists. Clinical, financial, and economic drivers were also evaluated. Finally, attention was given to issues applicable to deprescribing research, including difficulty recruiting trial participants, perspectives of investigators, and integration of findings into clinical practice. CONCLUSION: This narrative review summarizes key advances in the field while also identifying priority areas for additional research.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Zimmerman KM, Linsky AM. A narrative review of updates in deprescribing research. J Am Geriatr Soc. 2021. PMID: 33991423. doi:10.1111/jgs.17273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。